Table 3:
Demographic characteristics, laboratory site and cytology outcome, by vaccination dose
| Characteristic | No. (%) screened women | |||
|---|---|---|---|---|
| 0 doses n = 5712 |
1 dose n = 327 |
2 doses n = 490 |
≥ 3 doses n = 3675 |
|
| Age, yr* | ||||
| 18 | 120 (2.1) | 12 (3.7) | 25 (5.1) | 356 (9.7) |
| 19 | 478 (8.4) | 61 (18.7) | 138 (28.2) | 1289 (35.1) |
| 20 | 2065 (36.2) | 128 (39.1) | 186 (38.0) | 1515 (41.2) |
| 21 | 3049 (53.4) | 126 (38.5) | 141 (28.8) | 515 (14.0) |
| Neighbourhood income quintile | ||||
| 1 (lowest) | 1115 (19.5) | 66 (20.2) | 93 (19.0) | 607 (16.5) |
| 2 | 1170 (20.5) | 60 (18.3) | 100 (20.4) | 763 (20.8) |
| 3 | 1044 (18.3) | 57 (17.4) | 81 (16.5) | 667 (18.2) |
| 4 | 1201 (21.0) | 74 (22.6) | 115 (23.5) | 772 (21.0) |
| 5 (highest) | 1164 (20.4) | 68 (20.8) | 100 (20.4) | 857 (23.3) |
| Missing | 18 (0.3) | 2 (0.6) | 1 (0.2) | 9 (0.2) |
| Residential address | ||||
| Rural | 1592 (27.9) | 81 (24.8) | 116 (23.7) | 1084 (29.5) |
| Urban | 4102 (71.8) | 244 (74.6) | 373 (76.1) | 2582 (70.3) |
| Missing | 18 (0.3) | 2 (0.6) | 1 (0.2) | 9 (0.2) |
| Laboratory services | ||||
| Laboratory 1† | 2143 (37.5) | 146 (44.6) | 201 (41.0) | 1457 (39.6) |
| Laboratory 2‡ | 3569 (62.5) | 181 (55.4) | 289 (59.0) | 2218 (60.4) |
| Cytology outcome (worst result)§ | ||||
| Negative | 4794 (83.9) | 280 (85.6) | 407 (83.1) | 3242 (88.2) |
| Abnormal¶ | 918 (16.1) | 47 (14.4) | 83 (16.9) | 433 (11.8) |
| Low grade** | 846 (14.8) | 45 (13.8) | 82 (16.7) | 411 (11.2) |
| High grade†† | 72 (1.3) | 2 (0.6) | 1 (0.2) | 22 (0.6) |
*
Age when Pap test (worst result between Jan. 1, 2012, and Aug. 14, 2015) was performed.
†
Laboratory in Calgary.
‡
Laboratory in Edmonton.
§
Cytology with the worst result between Jan. 1, 2012, and Aug. 14, 2015.
¶
Abnormal: both low-grade and high-grade abnormalities.
**
Low-grade cases: atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.
††
High-grade cases: atypical squamous cells, cannot rule out a high-grade lesion; or high-grade squamous intraepithelial lesion.